0001567619-21-011167.txt : 20210525
0001567619-21-011167.hdr.sgml : 20210525
20210525184442
ACCESSION NUMBER: 0001567619-21-011167
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210521
FILED AS OF DATE: 20210525
DATE AS OF CHANGE: 20210525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bickerstaff George
CENTRAL INDEX KEY: 0001329646
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 21962203
MAIL ADDRESS:
STREET 1: C/O VION PHARMACEUTICALS, INC.
STREET 2: 4 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innoviva, Inc.
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1350 OLD BAYSHORE HIGHWAY
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 6502389600
MAIL ADDRESS:
STREET 1: 1350 OLD BAYSHORE HIGHWAY
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: THERAVANCE INC
DATE OF NAME CHANGE: 20020207
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4
1
doc1.xml
FORM 4
X0306
4
2021-05-21
0
0001080014
Innoviva, Inc.
INVA
0001329646
Bickerstaff George
1350 OLD BAYSHORE HIGHWAY, SUITE 400
BURLINGAME
CA
94010
1
0
0
0
Common Stock
2021-05-21
4
P
0
10000
12.9670
A
114560
D
Common Stock
2021-05-24
4
P
0
10000
13.4619
A
124560
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.9650 to $12.9670, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.24 to $13.54, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
/s/ George Bickerstaff
2021-05-25